Filter Results:
(653)
Show Results For
- All HBS Web
(653)
- People (2)
- News (222)
- Research (298)
- Events (4)
- Multimedia (12)
- Faculty Publications (180)
Show Results For
- All HBS Web
(653)
- People (2)
- News (222)
- Research (298)
- Events (4)
- Multimedia (12)
- Faculty Publications (180)
- 04 May 2020
- News
What the Coronavirus Crisis Reveals About American Medicine
- 21 Apr 2014
- News
Bio-Piracy: When Western Firms Usurp Eastern Medicine
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
Illustration by Jon Krause Illustration by Jon Krause Roger Frisch, a concert violinist with the Minnesota Orchestra, sees his instrument as an extension of himself—each time he pulls the bow across its strings, the vibrations seem to echo through him. So in June 2009,... View Details
Keywords: Janelle Nanos
- 14 Jun 2016
- News
HBS Alumna Now Kraft Precision Medicine Accelerator’s Codirector
- Article
How Harvard Business School Is Advancing Precision Medicine
By: Kathy Giusti and Richard G. Hamermesh
Giusti, Kathy, and Richard G. Hamermesh. "How Harvard Business School Is Advancing Precision Medicine." Journal of Precision Medicine (March 2020).
- October 2010 (Revised November 2010)
- Background Note
Plavix: Drugs in the Age of Personalized Medicine
By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
PIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon, and recently new data had been discovered that indicated that a small subset of the population would be at risk for stroke, heart attack, or even... View Details
Keywords: Health Care and Treatment; Product Positioning; Business and Government Relations; Genetics; Competitive Strategy; Pharmaceutical Industry
Hamermesh, Richard G., Mara G. Aspinall, and Rachel Gordon. "Plavix: Drugs in the Age of Personalized Medicine." Harvard Business School Background Note 811-001, October 2010. (Revised November 2010.)
- 22 Oct 2024
- News
National Academy of Medicine Elects 12 from Harvard
- 16 Dec 2016
- News
Search for a Youth Medicine Never Grows Old
- July 2002 (Revised August 2014)
- Case
WellSpace Treatment Centers for Complementary and Alternative Medicine (A)
By: Regina E. Herzlinger, Jun HuangPu and Bing Lin
How should WellSpace, a venture capital-backed purveyor of alternative health services, expand? Although it was nearing breakeven in its first location, the right business model remained unclear. View Details
Keywords: Business Model; Entrepreneurship; Venture Capital; Health Care and Treatment; Innovation and Invention; Service Delivery; Health Industry
Herzlinger, Regina E., Jun HuangPu, and Bing Lin. "WellSpace Treatment Centers for Complementary and Alternative Medicine (A)." Harvard Business School Case 303-017, July 2002. (Revised August 2014.)
- April 13, 2017
- Article
What Precision Medicine Can Learn from the NFL
By: Richard G. Hamermesh and Kathryn E. Giusti
Hamermesh, Richard G., and Kathryn E. Giusti. "What Precision Medicine Can Learn from the NFL." Forbes.com (April 13, 2017).
- Article
The Business of Medicine in the Era of COVID-19
By: David M. Cutler, Sayeh Nikpay and Robert S. Huckman
This Viewpoint discusses the shifting landscape of health care financing, regulation, and delivery as a result of the coronavirus pandemic, and discusses regulatory and other changes that need to be in place if telehealth and physician practice and hospital mergers... View Details
Keywords: Health Care; COVID-19; Telemedicine; Business; Health Pandemics; Health Care and Treatment; Change; Competition
Cutler, David M., Sayeh Nikpay, and Robert S. Huckman. "The Business of Medicine in the Era of COVID-19." JAMA, the Journal of the American Medical Association 323, no. 20 (May 26, 2020): 2003–2004.
- 01 May 2020
- News
The Business of Medicine in the Era of COVID-19
- November 2007
- Case
Center for Integration of Medicine and Innovative Technology (CIMIT)
By: H. Kent Bowen and Courtney Purrington
Translating innovative ideas form the clinician to the patient remains a major problem in the field of medicine. Dr. John Parrish and colleagues created an organization (CIMIT) that brings the technical, financial, and administrative resources to these innovative... View Details
Keywords: Financing and Loans; Innovation and Invention; Technological Innovation; Resource Allocation; Alliances; Research and Development; Health Industry; Service Industry
Bowen, H. Kent, and Courtney Purrington. "Center for Integration of Medicine and Innovative Technology (CIMIT)." Harvard Business School Case 608-036, November 2007.
- 14 Oct 2016
- News
The knotty problem of bringing regenerative medicine to market
- July 2002 (Revised August 2002)
- Case
Washington Hospital Center (D): Emergency Medicine After September 11
By: Rosabeth M. Kanter and Michelle Heskett
The all-risks-ready emergency room prototype project becomes widely accepted as a need after September 11, 2001. The already operational medical informatics system, Insight, comes under heavy demand after its strong performance during crises and is noticed by various... View Details